Squamous Cell Carcinoma of the Anal Canal (SCAC)Symptoms, Doctors, Treatments, Advances & More
Squamous Cell Carcinoma of the Anal Canal (SCAC) Overview
Learn About Squamous Cell Carcinoma of the Anal Canal (SCAC)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
City Of Hope Comprehensive Cancer Center-Duarte
Marwan Fakih is an Oncologist practicing medicine in Duarte, California. Dr. Fakih is rated as an Elite provider by MediFind in the treatment of Squamous Cell Carcinoma of the Anal Canal (SCAC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Liver Embolization, and Endoscopy.
Rockefeller Outpatient Pavilion
Julio Garcia-Aguilar is a Colorectal Surgeon practicing medicine in New York, New York. Dr. Garcia-Aguilar is rated as an Elite provider by MediFind in the treatment of Squamous Cell Carcinoma of the Anal Canal (SCAC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Ileostomy, and Colostomy. Dr. Garcia-Aguilar is currently accepting new patients.
Rockefeller Outpatient Pavilion
Emmanouil Pappou is a Colorectal Surgeon practicing medicine in New York, New York. Dr. Pappou is rated as an Elite provider by MediFind in the treatment of Squamous Cell Carcinoma of the Anal Canal (SCAC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Pappou is currently accepting new patients.
Summary: This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
Summary: The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken standard treatment options, have declined or have been ineligible for treatment with these medications. Participants with advanced or metastatic cancer who meet all eligibility criteria may be eligible to participate in the ...